BusinessCelldex Therapeutics Announces Appointment to Board of DirectorsBy Nasdaq OMXMar 1, 2017, 9:01 PM UTC
BusinessNewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial ResultsBy Nasdaq OMXFeb 28, 2017, 1:03 PM UTC
BusinessNewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial ResultsBy Nasdaq OMXFeb 28, 2017, 1:03 PM UTC
BusinessNewLink Genetics Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial ResultsBy Nasdaq OMXFeb 28, 2017, 1:03 PM UTC
BusinessUPDATED: Parnell to Report Financial Results for Fiscal Year 2016 on March 21, 2017By Nasdaq OMXFeb 27, 2017, 6:55 PM UTC
BusinessCatalyst Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare DiseasesBy Nasdaq OMXFeb 27, 2017, 1:03 PM UTC
BusinessEntia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products LineBy Nasdaq OMXFeb 24, 2017, 9:01 PM UTC
BusinessNivalis Therapeutics Announces Results from Phase 2 Clinical Trial of Cavosonstat Added to Ivacaftor for Treatment of Cystic FibrosisBy Nasdaq OMXFeb 23, 2017, 9:05 PM UTC
